Organovo Holdings, Inc. (0R02.L)
USD 0.26
(2.08%)
USD 0.26
(2.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 297 Thousand USD | 29699900.0% |
| 2022 | 1.00 USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 1.00 USD | -100.0% |
| 2018 | 490 Thousand USD | -41.81% |
| 2017 | 842 Thousand USD | 53.09% |
| 2016 | 550 Thousand USD | 64.67% |
| 2015 | 334 Thousand USD | 406.06% |
| 2014 | 66 Thousand USD | 4.76% |
| 2013 | 63 Thousand USD | -82.5% |
| 2012 | 360 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 408 Thousand USD | 37.37% |
| 2023 FY | 297 Thousand USD | 29699900.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | 297 Thousand USD | 29699900.0% |
| 2023 Q3 | 1.00 USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 1.00 USD | 0.0% |
| 2022 Q4 | 1.00 USD | 0.0% |
| 2022 Q3 | 1.00 USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | - USD | -100.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2019 Q4 | 1.00 USD | 0.0% |
| 2019 Q1 | 506 Thousand USD | 3.27% |
| 2019 Q2 | 351 Thousand USD | -30.63% |
| 2019 Q3 | - USD | -100.0% |
| 2019 FY | 1.00 USD | -100.0% |
| 2018 Q3 | 1.04 Million USD | 1.25% |
| 2018 Q2 | 1.03 Million USD | -0.77% |
| 2018 Q1 | 1.04 Million USD | 23.99% |
| 2018 Q4 | 490 Thousand USD | -53.29% |
| 2018 FY | 490 Thousand USD | -41.81% |
| 2017 FY | 842 Thousand USD | 53.09% |
| 2017 Q4 | 842 Thousand USD | 39.17% |
| 2017 Q3 | 605 Thousand USD | 21.98% |
| 2017 Q2 | 496 Thousand USD | 7.59% |
| 2017 Q1 | 461 Thousand USD | -16.18% |
| 2016 Q1 | 512 Thousand USD | 53.29% |
| 2016 Q4 | 550 Thousand USD | 67.68% |
| 2016 Q3 | 328 Thousand USD | -26.29% |
| 2016 Q2 | 445 Thousand USD | -13.09% |
| 2016 FY | 550 Thousand USD | 64.67% |
| 2015 FY | 334 Thousand USD | 406.06% |
| 2015 Q4 | 334 Thousand USD | 370.42% |
| 2015 Q3 | 71 Thousand USD | 4.41% |
| 2015 Q2 | 68 Thousand USD | -1.45% |
| 2015 Q1 | 69 Thousand USD | 4.55% |
| 2014 Q2 | 70 Thousand USD | -1.41% |
| 2014 FY | 66 Thousand USD | 4.76% |
| 2014 Q4 | 66 Thousand USD | -4.35% |
| 2014 Q1 | 71 Thousand USD | 12.7% |
| 2014 Q3 | 69 Thousand USD | -1.43% |
| 2013 Q2 | 74 Thousand USD | -12.94% |
| 2013 Q3 | 82 Thousand USD | 10.81% |
| 2013 FY | 63 Thousand USD | -82.5% |
| 2013 Q4 | 63 Thousand USD | -23.17% |
| 2013 Q1 | 85 Thousand USD | -3.41% |
| 2012 Q1 | 527.24 Thousand USD | 56.27% |
| 2012 Q3 | 360 Thousand USD | 15.32% |
| 2012 Q2 | 312.18 Thousand USD | -40.79% |
| 2012 Q4 | 88 Thousand USD | -75.56% |
| 2012 FY | 360 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | 337.39 Thousand USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Xeris Biopharma Holdings, Inc. | 38.83 Million USD | 99.235% |
| Arrowhead Pharmaceuticals, Inc. | - USD | -Infinity% |
| Codexis, Inc. | 2.68 Million USD | 88.939% |
| Viridian Therapeutics, Inc. | - USD | -Infinity% |